Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
After-Hours: 20:00
Evogene Profit Margin (Quarterly) : -458.5% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -458.5% |
| March 31, 2026 | -1.77K% |
| December 31, 2025 | -1.70K% |
| September 30, 2025 | -874.7% |
| June 30, 2025 | -563.7% |
| March 31, 2025 | -81.22% |
| December 31, 2024 | 63.71% |
| September 30, 2024 | -387.8% |
| June 30, 2024 | -752.6% |
| March 31, 2024 | -91.77% |
| December 31, 2023 | -1.27K% |
| September 30, 2023 | -102.4% |
| June 30, 2023 | -1.19K% |
| March 31, 2023 | -1.09K% |
| December 31, 2022 | -578.9% |
| September 30, 2022 | -1.54K% |
| June 30, 2022 | -3.13K% |
| March 31, 2022 | -3.84K% |
| December 31, 2021 | -2.60K% |
| September 30, 2021 | -5.53K% |
| June 30, 2021 | -5.11K% |
| March 31, 2021 | -2.14K% |
| December 31, 2020 | -2.50K% |
| September 30, 2020 | -1.71K% |
| June 30, 2020 | -1.62K% |
| Date | Value |
|---|---|
| March 31, 2020 | -9.62K% |
| December 31, 2019 | -5.77K% |
| September 30, 2019 | -4.67K% |
| June 30, 2019 | -2.16K% |
| March 31, 2019 | -1.08K% |
| December 31, 2018 | -918.0% |
| September 30, 2018 | -1.32K% |
| June 30, 2018 | -1.26K% |
| March 31, 2018 | -1.47K% |
| December 31, 2017 | -848.0% |
| September 30, 2017 | -671.7% |
| June 30, 2017 | -402.6% |
| March 31, 2017 | -672.3% |
| December 31, 2016 | -563.0% |
| September 30, 2016 | -332.9% |
| June 30, 2016 | -246.8% |
| March 31, 2016 | -167.3% |
| December 31, 2015 | -222.2% |
| September 30, 2015 | -102.2% |
| June 30, 2015 | -186.4% |
| March 31, 2015 | -126.2% |
| December 31, 2014 | -132.5% |
| September 30, 2014 | -132.1% |
| June 30, 2014 | -82.88% |
| March 31, 2014 | -60.59% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -269.3% |
| Pluri, Inc. | -1.85K% |
| Scinai Immunotherapeutics Ltd. | -435.4% |
| CollPlant Biotechnologies Ltd. | -2.52K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -140.6% |
| Return on Assets | -69.85% |
| Return on Invested Capital | -116.4% |
| Gross Profit Margin (Quarterly) | -2.31% |
| Operating Margin (Quarterly) | -703.5% |
| Return on Net Operating Assets | -358.8% |